Hospital Beatriz Angelo

Loures, Lisbon District 2674-514

0 studies enrolling now · 2 studies all time

What they study most

Advanced Cholangiocarcinoma, Carcinoma, Transitional Cell, FGFR2 Gene Mutation

Studies at this site

• Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations — Stopped early
• Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma — Completed